Kms Medisurgi Ltd vs Maitreya Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of KMS Medisurgi Ltd is ₹ 132.8 as of 13 May 15:30 . The P/E Ratio of KMS Medisurgi Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Maitreya Medicare Ltd changed from 30.8 on March 2024 to 0 on March 2026 . This represents a CAGR of -100.00% over 3 years The Market Cap of KMS Medisurgi Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Maitreya Medicare Ltd changed from ₹ 80.63 crore on March 2024 to ₹ 121.19 crore on March 2026 . This represents a CAGR of 14.55% over 3 years The Dividend Payout of KMS Medisurgi Ltd changed from 13.75 % on March 2021 to 6.6 % on March 2026 . This represents a CAGR of -11.51% over 6 yearsThe Dividend Payout of Maitreya Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About KMS Medisurgi Ltd

KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then has been launching new concepts which helped the Indian Healthcare industry.

About Maitreya Medicare Ltd

Maitreya Medicare Limited was originally incorporated as Maitreya Medicare Private Limited' at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC).
Thereafter, name of the Company was changed to Maitreya Medicare Limited' and a fresh Certificate of Incorporation was issued by the RoC on March 30, 2023.
Since then, Company engages in providing healthcare services and products. The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry.
The Company is a growing organization that aims at strengthening and establishing itself as foremost healthcare services provider.
It has a team of medical practitioners who ensures that patients get the quality healthcare services.

FAQs for the comparison of KMS Medisurgi Ltd and Maitreya Medicare Ltd

Which company has a larger market capitalization, KMS Medisurgi Ltd or Maitreya Medicare Ltd?

Market cap of KMS Medisurgi Ltd is 43 Cr while Market cap of Maitreya Medicare Ltd is 97 Cr

What are the key factors driving the stock performance of KMS Medisurgi Ltd and Maitreya Medicare Ltd?

The stock performance of KMS Medisurgi Ltd and Maitreya Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMS Medisurgi Ltd and Maitreya Medicare Ltd?

As of October 25, 2026, the KMS Medisurgi Ltd stock price is INR ₹132.8. On the other hand, Maitreya Medicare Ltd stock price is INR ₹144.55.

How do dividend payouts of KMS Medisurgi Ltd and Maitreya Medicare Ltd compare?

To compare the dividend payouts of KMS Medisurgi Ltd and Maitreya Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.